Clinical analysis by next-generation sequencing for NSCLC patients with MET amplification resistant to osimertinib.

scientific article published on 13 February 2018

Clinical analysis by next-generation sequencing for NSCLC patients with MET amplification resistant to osimertinib. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.LUNGCAN.2018.02.007
P698PubMed publication ID29571987

P2093author name stringLi Li
Jie Zheng
Yong He
Yubo Wang
Rui Han
Lin Jiao
P4510describes a project that usesmassive parallel sequencingQ6784807
P921main subjectnon-small-cell lung carcinomaQ3658562
P304page(s)105-110
P577publication date2018-02-13
P1433published inLung CancerQ641464
P1476titleClinical analysis by next-generation sequencing for NSCLC patients with MET amplification resistant to osimertinib.
P478volume118